Glucose is a simple sugar. It is a form of carbohydrate. It is the main source of energy for our bodies. Glycogen is the storage form of glucose in our bodies.
Glycogen storage diseases (GSDs) are a group of inherited genetic disorders. They cause glycogen to be improperly formed or released in the body. This results in a buildup of abnormal amounts or types of glycogen in tissues.
The main types of GSDs include:
Glycogen is mainly stored in the liver or muscle tissue. As a result, GSDs usually affect functioning of the liver, the muscles, or both.
GSDs are caused by a genetic enzyme defect. It is inherited from one or both parents.
Normally, enzymes help convert glucose into glycogen for storage. Other enzymes convert the glycogen back to glucose when energy is needed. This happens during activity like exercise. With GSD, some of these enzymes are defective, deficient, or absent.
The abnormal glycogen builds up in the liver and/or muscle tissues.
The main risk factor for GSDs is having a family member with this disease. The risk varies with the type of GSD.
Each type of GSD has specific symptoms.
Type 0 symptoms commonly appear in late infancy when night feedings stop. In the early morning the child may have low blood sugar which could cause:
The children may also have a mild growth delay. They also may have poor exercise tolerance.
Type I may appear as early as 3 months old. Common symptoms include:
Copyright © Nucleus Medical Media, Inc.
Type II is broken into the time of symptom onset. Infants generally show symptoms at 4-8 months of age. Type II can also form in childhood, adolescence, or adulthood.
Infant-onset Type II GSD symptoms include:
Late-onset Type II GSD symptoms include:
Type III may appear in childhood. Common symptoms include:
Type IV appears during infancy. Common symptoms include:
Common symptoms of Type V include:
Symptoms may not appear in people with Types VI or XI. When they do occur, symptoms include:
Common symptoms of Type VII include:
You will be asked about your child's symptoms and medical history. A physical exam will be done. Diagnosis of GSDs usually occurs in infancy or childhood. It is often done by the symptoms listed above. Tests may include:
Your child's bodily fluids and tissues may be tested. This can be done with:
Images may be need of your child's bodily structures. This can be done with an MRI scan.
This test may be used for an early diagnosis on some types of GSD. It is often done when there is a family history.
In this technique eggs and sperm are harvested from a couple who have a known risk. The egg is fertilized in the lab. The GSD free embryo is then implanted within the mother’s uterus. This technique allows parents to have additional unaffected children. This process may still pose ethical or religious concerns for some couples.
Treatment will depend on the type of GSD and the symptoms. Your doctor will develop a plan based on your specific symptoms.
People with Type 0 need to manage their blood sugar throughout the day. This means frequent meals or snacks every few hours. Uncooked cornstarch provides a steady, slow release of glucose and may help prevent low blood sugar in the overnight hours. Other considerations includes eating high amounts of protein.
Treatment for Type I includes eating small, frequent meals throughout the day. People with Type I may have to restrict certain sugars. This may include sugar found in fruits, juice, and candy. Eating uncooked cornstarch is also necessary. Many people will need to take a multivitamin.
Medications and procedure may be needed to control complications of Type 1 GSD.
Type II is treated with enzyme replacement therapy. Alglucosidase alpha is given by IV infusion.
People with Type III need to manage their blood sugar throughout the day. This means frequent meals or snacks every few hours. Diet for Type III includes high amounts of carbohydrates and cornstarch. Those with weak muscle involvement are generally put on a diet with high protein intake.
Liver transplant surgery may be necessary for some people who develop liver cancer or have liver failure.
Type IV treatment focuses on treating progressive liver disease and its complications. Ultimately, a liver transplant may be necessary to survive. This does not improve damage to the muscles from the condition though.
There is no specific treatment for people with Type V GSD. Changing exercise patterns and avoiding certain activities may be important to help manage this condition. Exercise tolerance may be improved by ingestion of some sugars prior to starting exercise.
Treatment includes cornstarch to avoid low blood sugars and eating adequate amounts of protein. Frequent meals may also be needed to help avoid low blood sugars. These changes can help promote normal growth and development.
Type VII treatment focuses on avoiding high muscle stress. This can be accomplished by reducing strenuous exercise to manageable levels. In some people, high protein intake has helped with muscle weakness.
Association for Glycogen Storage Disease
Canadian Health Network
Canadian Institute for Health Information
Glycogen and glycogen storage diseases. The Association for Glycogen Storage Disease website. Available at: http://www.agsdus.org/html/glycogenandgsds.html. Accessed March 10, 2016.
Glycogen storage disease type I (von Gierke disease). EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T116734/Glycogen-storage-disease-type-I-von-Gierke-disease. Updated February 10, 2015. Accessed March 10, 2016.
Glycogen storage disease type II (Pompe disease). EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T116933/Glycogen-storage-disease-type-II-Pompe-disease. Updated May 25, 2016. Accessed September 23, 2016.
Glycogen storage disease type III (Cori disease). EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T114690/Glycogen-storage-disease-type-III-Cori-disease. Updated January 20, 2011. Accessed March 10, 2016.
Glycogen storage disease type IV (Anderson disease). EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T116467/Glycogen-storage-disease-type-IV-Andersen-disease. Updated January 20, 2011. Accessed March 10, 2016.
Glycogen storage disease type V (McArdle syndrome). EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T116706/Glycogen-storage-disease-type-V-McArdle-syndrome. Updated November 25, 2014. Accessed March 10, 2016.
Glycogen storage disease type VI (Hers' disease). EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T114654/Glycogen-storage-disease-type-VI-Hers-disease. Updated February 22, 2010. Accessed March 10, 2016.
Hypoglycemia. National Diabetes Information Clearinghouse website Available at: http://diabetes.niddk.nih.gov/dm/pubs/hypoglycemia. Updated October 2008. Accessed March 10, 2016.
5/28/2010 DynaMed Plus Systematic Literature Surveillance http://www.dynamed.com/topics/dmp~AN~T116933/Glycogen-storage-disease-type-II-Pompe-disease: FDA approves new treatment for late-onset Pompe disease. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm213282.htm. Updated May 25, 2010. Accessed March 10, 2016.
Last reviewed March 2017 by EBSCO Medical Review Board Kari Kassir, MD
Copyright © 2012 EBSCO Publishing All rights reserved.
What can we help you find?close ×